Matrix metalloproteinase-9 (MMP-9) Expression in Non-Small Cell Lung Carcinoma and Its Association with Clinicopathologic Factors

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 148

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJP-15-4_011

تاریخ نمایه سازی: 26 آذر 1399

Abstract:

Background & Objective:  Matrix metalloproteinases-9 (MMP-9) is one of the most important enzymes to breakdown extracellular matrix which plays a major role in tumor invasion and metastasis. This study aimed to determine tumor MMP-9 expression in non-small-cell lung carcinoma (NSCLC) and whether it is associated with histopathologic factors and has prognostic value to affect overall survival (OS). Methods:  The specimens of 92 patients with NSCLC diagnosis were included. Tumor sections were stained by immunohistochemistry method. Using scores for the percentage of cells positively stained and the intensity of staining, MMP-9 expression total score was classified as low-score (scores of 0 to 2), moderate-score (scores of 3 to 5), or high-score (scores of 6 or 7). OS was defined as the time interval since the diagnosis of NSCLC to the status at the last follow-up (dead or alive). The follow up period was up to 70 months.   Results:  About 74% of undifferentiated specimens (grade III tumors) showed high scores for MMP-9 expression which was significantly higher than moderately differentiated tumors (25% had high scores for MMP-9 expression) and well differentiated ones which did not have high scores (p <0.001). A total of 74 patients (80.4%) died during the follow-up period. Of this, 36% had high scores for MMP-9 expression. In contrast, none of the patients who were alive at the last follow-up had high scores for MMP-9 expression (p <0.001). Median OS was significantly lower in high score group (6 months) compared to moderate score (9 months) and high score group (15 months) (p <0.001). Conclusion:  MMP-9 expression may serve as a significant prognostic factor for mortality and overall survival in NSCLC. Undifferentiated tumors significantly express higher MMP-9 immunohistochemically.

Authors

Amir Hossein Jafarian

Pathology Department, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Melika Kooshki forooshani

Pathology Department, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Hossein Reisi

Pathology Department, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Nema Mohamadian roshan

Pathology Department, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA ...
  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, ...
  • Cooke DT, Nguyen DV, Yang Y, Chen SL, Yu C, ...
  • Hubbard MO, Fu P, Margevicius S, Dowlati A, Linden PA. ...
  • Han JY, Kim HS, Lee SH, Park WS, Lee JY, ...
  • Cox G, Jones JL, O'Byrne KJ. Matrix metalloproteinase 9 and ...
  • Willumsen N, Bager CL, Leeming DJ, Smith V, Christiansen C, ...
  • Wen YL, Li L. Correlation between matrix metalloproteinase-9 and vascular ...
  • Gong L, Wu D, Zou J, Chen J, Chen L, ...
  • Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, ...
  • Vandooren J, Van den Steen PE, Opdenakker G. Biochemistry and ...
  • Shao W, Wang W, Xiong XG, Cao C, Yan TD, ...
  • Lee CY, Shim HS, Lee S, Lee JG, Kim DJ, ...
  • Stenvold H, Donnem T, Andersen S, Al-Saad S, Al-Shibli K, ...
  • Shi M, Cao M, Song J, Liu Q, Li H, ...
  • Chee-Keong Toh. The Changing Epidemiology of Lung Cancer. 2009. 19: ...
  • Wei Dong, Hong Li, Yan Zhang, et al. Matrix metalloproteinase ...
  • Rydlova M, Holubec L, Jr., Ludvikova M, Jr., Kalfert D, ...
  • Mehner C, Hockla A, Miller E, Ran S, Radisky DC, ...
  • Safranek J, Pesta M, Holubec L, Kulda V, Dreslerova J, ...
  • El-Badrawy MK, Yousef AM, Shaalan D, Elsamanoudy AZ. Matrix metalloproteinase-9 ...
  • Pinto CA, Carvalho PE, Antonangelo L, Garippo A, Da Silva ...
  • Zheng S, Chang Y, Hodges KB, Sun Y, Ma X, ...
  • Sienel W, Hellers J, Morresi-Hauf A, Lichtinghagen R, Mutschler W, ...
  • Grossi F, Spizzo R, Bordo D, Cacitti V, Valent F, ...
  • Weiling He , Hui Zhang , Yuefeng Wang , Yanbin ...
  • Vincenti MP. The matrix metalloproteinase (MMP) and tissue inhibitor of ...
  • A. Churg, R. Wang, X. Wang, P.O. Onnervik, K. Thim, ...
  • Balla, M., Desai, S., Purwar, P. et al. Differential diagnosis ...
  • Hao Huang, Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and ...
  • نمایش کامل مراجع